Healthcare provider profile · identity verified

Lori Bigi

Internal Medicine · SEWICKLEY, PA · NPI 1093787137

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	524	150
Losartan Potassium	Losartan Potassium	422	125
Levothyroxine Sodium	Levothyroxine Sodium	362	96
Amlodipine Besylate	Amlodipine Besylate	322	97
Rosuvastatin Calcium	Rosuvastatin Calcium	280	90
Pantoprazole Sodium	Pantoprazole Sodium	199	48
Lisinopril	Lisinopril	181	58
Metoprolol Succinate	Metoprolol Succinate	177	51
Omeprazole	Omeprazole	173	54
Gabapentin	Gabapentin	164	46
Eliquis	Apixaban	153	27
Sertraline Hcl	Sertraline Hcl	153	37
Hydrochlorothiazide	Hydrochlorothiazide	131	45
Metformin Hcl Er	Metformin Hcl	129	39
Pravastatin Sodium	Pravastatin Sodium	120	44
Duloxetine Hcl	Duloxetine Hcl	113	33
Albuterol Sulfate Hfa	Albuterol Sulfate	86	31
Simvastatin	Simvastatin	82	24
Alendronate Sodium	Alendronate Sodium	80	25
Zolpidem Tartrate	Zolpidem Tartrate	77	13
Valsartan	Valsartan	75	19
Ozempic	Semaglutide	74	12
Potassium Chloride	Potassium Chloride	74	25
Oxycodone Hcl	Oxycodone Hcl	72	12
Tamsulosin Hcl	Tamsulosin Hcl	71	21
Trazodone Hcl	Trazodone Hcl	70	18
Ezetimibe	Ezetimibe	69	25
Famotidine	Famotidine	69	18
Synthroid	Levothyroxine Sodium	69	17
Atenolol	Atenolol	67	19
Spironolactone	Spironolactone	67	21
Metformin Hcl	Metformin Hcl	66	19
Fluoxetine Hcl	Fluoxetine Hcl	64	17
Montelukast Sodium	Montelukast Sodium	62	21
Allopurinol	Allopurinol	57	14
Carvedilol	Carvedilol	56	19
Metoprolol Tartrate	Metoprolol Tartrate	56	19
Escitalopram Oxalate	Escitalopram Oxalate	55	16
Fluticasone Propionate	Fluticasone Propionate	55	18
Furosemide	Furosemide	54	24
Citalopram Hbr	Citalopram Hydrobromide	52	12
Meloxicam	Meloxicam	51	14
Doxycycline Hyclate	Doxycycline Hyclate	50	34
Tramadol Hcl	Tramadol Hcl	43	13
Xarelto	Rivaroxaban	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	14
Colchicine	Colchicine	39	suppressed
Alprazolam	Alprazolam	38	16
Celecoxib	Celecoxib	38	suppressed
Jardiance	Empagliflozin	38	suppressed
Irbesartan	Irbesartan	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	29
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	14
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	18
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Methylprednisolone	Methylprednisolone	27	25
Triamcinolone Acetonide	Triamcinolone Acetonide	27	18
Chlorthalidone	Chlorthalidone	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Finasteride	Finasteride	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	14
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Azithromycin	Azithromycin	23	22
Bupropion Xl	Bupropion Hcl	23	suppressed
Lorazepam	Lorazepam	23	11
Warfarin Sodium	Warfarin Sodium	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nystatin	Nystatin	22	suppressed
Repatha Sureclick	Evolocumab	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	12
Farxiga	Dapagliflozin Propanediol	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Topiramate	Topiramate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Cephalexin	Cephalexin	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Primidone	Primidone	16	suppressed
Cefuroxime	Cefuroxime Axetil	15	11
Mirtazapine	Mirtazapine	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Prednisone	Prednisone	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Epinephrine	Epinephrine	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Jentadueto	Linagliptin/Metformin Hcl	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error